| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008818 | Annals of Allergy, Asthma & Immunology | 2005 | 5 Pages |
Abstract
High-dose immunotherapy in children younger than 5 years does not cause more adverse reactions than in children aged 5 to 7 years. There is no reason to forbear studies on safety and efficacy of these preparations in young children.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Alessandro MD, Giovanbattista MD, Stefania MD, Francesco MD, Cristoforo MD, Laura MD, Francesco MD, Franco MD,